🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congrats to DrBagrodia, Dr. Sarah Marietti-Shepherd, and Seth Bechis on their respective promotions to Professor of Urology! We’re proud of your many accomplishments and grateful for your contributions to the department!

🔥 What’s the hottest topic in oncology right now? CANCER + THE MICROBIOME. We reviewed the current evidence on how manipulating the gut microbiome can enhance immunotherapy, and what’s next. Led by @MontyPal with insights from Zeynep Zengin and me. 📍Read here:

I’m signed up! I’ve had the pleasure of hearing Kimryn Rathmell speak on many occasions and she is always inspirational! 💡🧬🥼

⭐️ We acknowledge that positive phase II trials don’t always translate into positive phase III results ⭐️Enrollment is challenging in non-clear cell but can be done! ⭐️Industry support can make phase III trials possible and even help accelerate enrollment

David Braun on the journey of taking personalized vaccines from concept to clinic #kcrs25 KidneyCAN

Excellent work by David Braun at #KCRS25 Personalized vaccines in kidney cancer, turning concept into clinic. Immune activation, navigation, precision. The future is driving fast. KidneyCAN IKCC Kidney Cancer Bryan Lewis Toni Choueiri, MD Hans Hammers OncoAlert Sumanta K. Pal, MD, FASCO Nazli Dizman

Look at some of the impact of DOD CDMRP funding. David Braun is presenting the personalized vaccine in RCC published in nature. Please restore funding. It went from $50 Million to $0 Dollars. We have not solved cancer yet! KidneyCAN #KCRS25

👏👏 Check out the illustration of the excellent Keynote Session packed with wisdom pearls by one and only Kimryn Rathmell 🙏 #Acceleratingcures Toni Choueiri, MD Hans Hammers Sumanta K. Pal, MD, FASCO ari hakimi Rana McKay, MD, FASCO Tom Powles KidneyCAN Susan Poteat Laurence Albiges Kelly Fitzgerald Yasserged

Wonderful presentation by Ruchi Agarwal highlighting global disparities in clinical trial availability for RCC. A crucial reminder of the inequities that persist and the urgent need for more inclusive research efforts. #KCRS25

Congratulations to Rana McKay, MD, FASCO for receiving the #KCRS25 Catalyst Award! 👏 A true leader, collaborator, and innovator in kidney cancer research. Well deserved! KidneyCAN OncoAlert Toni Choueiri, MD Hans Hammers Sumanta K. Pal, MD, FASCO Nazli Dizman Emre Yekedüz @asco Michael Serzan, MD ari hakimi

Hidden gem 💎 💎 #KCRS25 The CONTACT3 trial showed sequencing PD1 and PDL1 therapy was not benificisl in renal cancer. Bradley McGregor explores whether 2nd line Cabozantinib is more active after prior ipi/nivo or VEGF/PD1 with surprising results OncoAlert Toni Choueiri, MD Sumanta K. Pal, MD, FASCO

💡 Great review of progress over the last 10 years in 1st-line metastatic RCC 🚀 and a call from David McDermott to work together to cure more patients with kidney cancer 🤝 KidneyCAN #KCRS25 #rcc #kidneycancer

One of the reasons I love KidneyCAN's #KCRS25: Hearing luminaries in the field of #kidneycancer present their take on data hot off the press. So cool to see Toni Choueiri, MD Robert Motzer MD Naomi Haas #McDermott sharing a stage & offering perspective on the latest from ASCO, ESMO - Eur. Oncology &

What an incredible slide from Wenxin (Vincent) Xu at #KCRS2025 depicting some of the individuals that have contributed to biomarker research in RCC 🔬. “Biomarkers are a lot of work, but they will reduce both overtreatment and undertreatment” KidneyCAN OncoAlert

#KCRS25 Session 5 focused on current best practices and what's ahead in kidney cancer treatment and research. Front-Line Treatment Approaches with David McDermott Subsequent-Line Options with Robert Motzer MD Adjuvant Therapy Options with Naomi Haas Treatment of Rare Subtypes with

We’re proud to present the KidneyCAN Catalyst Award to Dr. Rana McKay of UC San Diego. Dr. McKay is a leader whose work has helped move the field of kidney cancer forward through groundbreaking research, clinical collaboration, and a deep commitment to patients and advocacy. Her

Congrats Rana McKay, MD, FASCO! Very proud to be part of the GU team at UCSD. DrBagrodia Tyler Seibert MD PhD DrTylerStewart Amir Salmasi Diane M. Simeone, MD UCSD Urology KidneyCAN

Yu-Wei Chen, MD, MS Rana McKay, MD, FASCO DrBagrodia DrTylerStewart Amir Salmasi Diane M. Simeone, MD UCSD Urology KidneyCAN Indeed! Rana McKay, MD, FASCO is a powerhouse. I love our GU team UC San Diego Health Moores Cancer Center, and her leadership is incredibly impactful

Great meeting!! Thank you everyone and in particular to our patient volunteers! Save the date for July 23/24 2026! #KCRS25 KidneyCAN

"We need to have a focused effort and create awareness to reduce the rising impact of alcohol-associated cancer mortality.” -Reads The ASCO Post article on our study Sylvester Comprehensive Cancer Center gilberto lopes Dr. Estela Rodriguez Miami Hem/Onc Program Director ASCO ascopost.com/news/july-2025…